The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain
|ClinicalTrials.gov Identifier: NCT01954199|
Recruitment Status : Completed
First Posted : October 1, 2013
Last Update Posted : June 2, 2016
|Condition or disease||Intervention/treatment||Phase|
|Nerve Pain Peripheral Nerve Injuries Peripheral Nervous System Diseases Sciatica Low Back Pain Low Back Ache Signs and Symptoms||Procedure: Neurodynamic Group||Not Applicable|
Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain.
Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP.
Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain|
|Study Start Date :||March 2015|
|Actual Primary Completion Date :||April 2016|
|Actual Study Completion Date :||April 2016|
Experimental: Neurodynamic group
Patients allocated to this group will receive three different neurodynamic techniques: a lumbar foramen dynamic opener; a side-lying slider and a slider in the slump position. Patients will be asked to perform home exercises (a slider and a tensioner technique). Treatment will receive four treatments during two weeks (two sessions/week).
Procedure: Neurodynamic Group
All techniques will be executed in a pain-free way (grade III). Mild discomfort will be accepted, but it must subside as soon as the technique ends.
No Intervention: Control Group
Patients allocated to Control Group (CG) will receive no intervention and will be advised according to the best evidence available; i.e, advice to remain active and to resume activities of daily living
Upon trial completion, treatment will be offered.
- Leg Pain Intensity [ Time Frame: Two weeks after randomization ]Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS)
- Disability [ Time Frame: Two weeks after randomization ]Disability will be measured by the Oswestry Disability Index (ODI)
- Leg pain Intensity [ Time Frame: Four weeks after randomization ]Leg Pain will me measured by a 0-10 Pain NRS
- Disability [ Time Frame: Four weeks after randomization ]Disability will be measured by the Oswestry Disability Index (ODI)
- Back pain intensity [ Time Frame: Two weeks after randomization ]Back Pain will me measured by an 0-10 Pain NRS
- Back pain intensity [ Time Frame: Four weeks after randomization ]Back Pain will me measured by an 0-10 Pain NRS
- Distribution of Symptoms [ Time Frame: Two weeks, Four weeks after randomization ]Distribution of symptoms will me measured by a body diagram
- Function [ Time Frame: Two weeks, Four weeks after randomization ]Function will be measured by the Patient-Specific Functional Scale (PSFS)
- Global Perceived Effect [ Time Frame: Two weeks, Four weeks after randomization ]Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01954199
|Federal University of Health Sciences of Porto Alegre|
|Porto Alegre, Rio Grande do sul, Brazil, 90050-170|
|Study Chair:||Marcelo F Silva, PhD||Federal University of Health Sciences of Porto Alegre|